Lorlatinib: Tablet 25 mg, Tablet 100 mg; Lorviqua® Page last updated: 4 March 2022 Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 1090KB) Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 89KB)